|
Biology and Biotechnology Patent Prosecution
Intellectual property is the cornerstone of businesses in the field of biotechnology, whether a start-up or a Fortune 500 company. The firm has many decades of experience in creating value for biotechnology. Our attorneys have the technical expertise and experience to develop pro-active strategies, integrated with product development, to protect and defend critical intellectual property rights in all areas of biotechnology. Clients rely on us to develop patent acquisition and management strategies in the United States and internationally through patent application through foreign Patent Offices around the world and through Patent Cooperation Treaty (PCT) applications, and to provide information and analysis useful in steering the direction of research to avoid or minimize obstacles.
Experienced and technically skilled Rothwell, Figg, Ernst & Manbeck attorneys prepare patent applications with the broadest possible coverage and prosecute them to issuance in areas such as:
- agriculture and genetically modified crops
- antibodies
- antisense technology
- bioinformatics, genomics and proteomics
- cell biology
- fermentation
- forensics and DNA fingerprinting
- gene amplification methodologies
- hormones
- microarrays (biochips)
- neurobiology
- peptide and protein chemistry
- plants
- recombinant DNA methodologies and constructs
- RNA interference technology
- screening and research tools
- transgenics
- vaccines
- viral delivery systems.
Our attorneys also handle reissue and reexamination proceedings, interferences, and advise our clients regarding potential partners. In addition, we provide assistance with strategies to design around the competition and manage the risk of infringing others’ intellectual property, as well as enforcement of intellectual property rights, through litigation or other means. |
